$COHN

Cohen & Company Sets Release Date for Third Quarter 2025 Financial Results

PHILADELPHIA and NEW YORK, Oct. 31, 2025 ( GLOBE NEWSWIRE ) -- Cohen & Company Inc. ( NYSE American: COHN ) will release its financial results for the third quarter 2025 on Tuesday, November 4, 2025. The Company will host a conference call at 10:00 a.m. Eastern Time ( ET ) that day to discuss ...

Original reporting
GlobeNewswire · Cohen & Company Inc.
Published Oct 31, 2025, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 31, 2025, 8:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cohen & Company Sets Release Date for Third Quarter 2025 Financial Results — source image
Decision brief

The 30-second read

$COHNNeutralMed
01

Why it matters

The upcoming earnings release is a key event that could influence the company's stock price and investor sentiment.

02

Market read

The event is highly relevant for investors and traders focusing on the financial sector, especially those holding or considering positions in COHN.

03

What to watch

Broader market trends and macroeconomic factors could overshadow company-specific news, reducing the impact of earnings on stock performance.

Relevance 6/10Timing: High, as the earnings release is scheduled for November 4, 2025.

Background

Cohen & Company Inc. is a financial services firm scheduled to announce its Q3 2025 financial results.

Company-level read

Ticker impact

$COHNNeutralMedium confidence
Context

Primary focus due to company's upcoming earnings release.

Expected impact

Potential short-term increase or decrease depending on earnings results; no definitive movement expected prior to release.

Evidence & confidence

Earnings releases are significant catalysts; however, without prior earnings estimates or consensus data, the market reaction remains uncertain.

Market effects

The earnings report may influence investor sentiment within the financial services sector.

Limited regional impact expected; primarily affecting US-based investors.

Minimal global market relevance, as the event pertains to a single company's earnings.

Counterpoint

Earnings results may be in line with expectations, leading to minimal stock movement.

Key entities

  • Cohen & Company Inc.

    A financial services firm listed on NYSE American.

Related articles

$COHNMed

COHEN & COMPANY REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Cohen & Co Inc. (COHN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 COHEN & COMPANY REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS Board Declares Quarterly Dividend of $0.25 per Share Revenue of $69.5 Million Net Income Attributable to Cohen & Company Inc. of $3.6 Million, or $0.94 per Diluted Share Adjusted Pre-Tax Income of $10.1 Mi

$COHNMedAI 8/10

2026 - 06 - 26 | Elroy Air to Become Publicly Traded Company via Business Combination with Inflection Point - led SPAC | NDAQ: CMII

Elroy Air will become a publicly traded company through a business combination with SPAC Columbus Circle Capital Corp II (Nasdaq: CMII), led by Inflection Point Asset Management. The deal values Elroy Air at about $800M pre-money and ~$1.0B enterprise value, with $165M+ committed PIPE capital. Closing is expected in Q4 2026. Elroy’s Chaparral VTOL drone targets 500+ lbs cargo; demand pipeline exceeds 1,400 aircraft and $5B potential revenue.

$BMYMed

Bristol Myers Squibb Reports CAR T-Cell Therapy Data In Multiple Sclerosis

Bristol Myers Squibb (BMY) reported interim Phase 1 Breakfree-2 study results for its CAR T-cell therapy zolacabtagene autoleucel in 66 multiple sclerosis patients. 92% of progressive MS patients showed stable or improved disability. Safety issues included cytokine release syndrome in 42.4% of patients. BMY stock is down 2.26% at $61.56.